A study to assess the efficacy of an emollient cream in reducing skin reactions of patients treated for their Actinic Keratosis with 5- fluorouracil 4% treatment

tolak logo

Frequency and Intensity of local reactions in patients treated with 4% 5-FU vs 4% 5-FU associated with an emollient cream: a randomised, controlled clinical trial

Hide study title

How is the study conducted?

This study has to recruit 145 European participants from France, Germany, Italy and Spain with actinic keratosis lesions on their face, and/or ears and/or scalp. The total duration of the study for each participant is 8 weeks including 4 visits (inclusion visit, Week 2, Week 4 and Week 8).

This study is randomised, meaning that participants are assigned to one of the treatment groups using an element of chance. The randomisation ratio is 1:1, which means that participant has the same probability to receive 5-fluorouracil 4% with an emollient cream than 5-fluorouracil 4% only.

The schema summarizes the information presented above:

Tolak Schema

Who can take part in the trial ?

To be part of the trial, participant must fulfill several conditions including the following:

• The participant is at least 18 years old

• The participant has a clinical diagnosis of actinic keratosis (AK).

• The participant is harboring 5 or more clinically recognizable (palpable and/or visible to unaided eye) AK lesions of the face, and/or ears and/or scalp.

• AK lesions of the treated area are not cancerous

• The participant does not present important local skin reactions before treatment initiation

What are the objectives of the trial and how are they evaluated ?

The primary objective is to compare the Local Skin Reaction score (LSR score) on the area treated at the end of 4-weeks therapy between the group of patients having received 5-fluorouracil 4% associated with an emollient cream (called the intervention group) and the group of patients having received 5-fluorouracil 4% only (called the control group).

The LSR score includes the evaluation of 6 usual types of skin reactions:

- erythema (the redness of the skin),

- erosion and ulceration (losses of superficial parts of the skin that can lead to a sore),

- swelling (skin oedema),

- crusting,

- flaking and scaling (related to an excessive dryness of the skin),

- vesiculation and pustulation (appearance of small blisters filled with fluid).

The score is assessed by the doctor and ranges from 0 (absence of skin reaction) to a maximum of 24 (maximal severity for all types of reactions).

In addition, secondary objectives of the trial include:

• A comparison of the local skin reaction during 5-fluorouracil 4% treatment course between patients with and without emollient cream based on the patients' self-evaluations (subjective symptoms).

• A comparison of the tolerability to 5-fluorouracil 4% therapy between patients with and without emollient cream. The tolerability is assessed regarding proportion of patients who stopped their treatment prematurely due to a side effect related to local skin reactions.

• A comparison of the clinical response to 5-fluorouracil 4% therapy between patients with and without emollient cream. The clinical response is assessed regarding the evolution of number of AK lesions from trial entry to 4 weeks after the end of the therapy.

What is the study Medication ?

Both study products are approved and marketed in countries of Europe. 5-fluorouracil 4% (Tolak®) is a cream indicated in adults for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis lesions on the face and/or ears and/or scalp.

Dexeryl® is an emollient cream containing glycerol, vaseline and paraffin, marketed as a non-medicinal treatment for signs and symptoms of skin dryness in various skin diseases.

Participants receive:

• Either 5 fluorouracil 4% (Tolak®) associated with the emollient cream (Dexeryl®) for 8 weeks,

• Or 5 fluorouracil 4% only.

5 fluorouracil 4% cream was to be applied once daily in the evening for 4 weeks

Emollient cream was to be applied once daily in the morning for 8 weeks.


Study primary results :

Send by email